Masters Speciality Pharma partners with medical professionals and health-care institutions to supply high quality, life changing medicines patients need, when they need them.
Whether the need is for unlicensed drugs (through Masters Specialty Access) or our own trusted brand of Masters products or locally registered medicines (through Masters Specialty Medicines), our customers know that we adhere to the highest standards of ethics, quality, regulatory compliance and governance.
With a 30+ year track record, we have proven supply chain capabilities and unrivalled access to Southern and Central America, the Caribbean and the Middle East. We specialise in sourcing medicines from the UK, Europe and US to treat oncology, haematology, pain management and rare and orphan diseases. We also have ambitious plans to grow the company substantially in the rare disease market and also in the therapeutic areas of oncology, haematology and endocrinology.
Employees share the entrepreneurial vision of our founder and are committed to making a difference to the lives of people in the developing world by ensuring medicines always reach their destination in perfect condition. This is embodied in our guiding mantra of ‘medicines reaching further’.
Moreover, our experience of successfully addressing differing and often complex regulatory requirements, particularly in emerging markets, ensures that Masters is ideally placed to meet demand for both new and established medicines..